- Home
- HSDT vs CBUS Comparison
HSDT vs CBUS Comparison
Compare HSDT & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSDT | CBUS |
|---|---|---|
| Founded | N/A | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.8M | 142.7M |
| IPO Year | 2014 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HSDT | CBUS |
|---|---|---|
| Price | $2.72 | $1.63 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $4.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 408.7K | 92.9K |
| Earning Date | 05-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 57.27 | ★ 74.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,017,000.00 | $3,639,000.00 |
| Revenue This Year | $91.56 | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1057.12 | N/A |
| 52 Week Low | $1.19 | $1.09 |
| 52 Week High | $22.28 | $4.19 |
Technical Indicators
Market Signals| Indicator | HSDT | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 69.64 | 50.07 |
| Support Level | $2.68 | $1.64 |
| Resistance Level | $3.68 | $1.82 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 97.20 | 82.76 |
Price Performance
Historical ComparisonAbout HSDT Helius Medical Technologies Inc. (DE)
Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.